SynAct Pharma AB (STO:SYNACT)
Sweden · Delayed Price · Currency is SEK 17.90
0.00 (0.00%)
Sep 22, 2026, 5:29 PM CET
SynAct Pharma AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -106.14 | -110.83 | -82.4 | -215.81 | -99.21 | -69.3 |
Depreciation & Amortization | 0.63 | 0.63 | 0.62 | 75.34 | 1.02 | 0.09 |
Loss (Gain) From Sale of Assets | - | - | -0.05 | -0.04 | -0.01 | - |
Stock-Based Compensation | 1.89 | 1.89 | 10.07 | 7.88 | - | - |
Other Operating Activities | 2.97 | 3.49 | 0.85 | 2.09 | 1 | -2.88 |
Change in Accounts Receivable | 13.3 | 13.3 | -19.63 | 19.87 | -19.31 | -1.21 |
Change in Accounts Payable | -7.04 | -7.04 | 7.33 | 5.11 | 0.18 | 1.44 |
Change in Other Net Operating Assets | -22.82 | 1.22 | -5.97 | 5.39 | -1.22 | 6.87 |
Operating Cash Flow | -117.21 | -97.33 | -89.2 | -100.18 | -117.56 | -65 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Investment in Securities | - | - | - | 0.37 | 0.03 | -0.01 |
Other Investing Activities | -13.89 | - | - | - | - | - |
Investing Cash Flow | -13.89 | - | - | 0.37 | 0.03 | -0.01 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -0.58 | -0.6 | -0.73 | -0.98 | -0.08 |
Lease Payments | -0.58 | -0.58 | -0.6 | -0.73 | -0.98 | -0.08 |
Net Debt Issued (Repaid) | -0.58 | -0.58 | -0.6 | -0.73 | -0.98 | -0.08 |
Issuance of Common Stock | 144.12 | 92.21 | 94.14 | 59.46 | 228.95 | 80 |
Other Financing Activities | -61.53 | -1.18 | -6.14 | -4.75 | -27.25 | -5.6 |
Financing Cash Flow | 77.01 | 90.46 | 87.41 | 53.98 | 200.71 | 74.32 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.57 | -0.93 | 0.61 | -0.03 | 1.06 | 0.13 |
Miscellaneous Cash Flow Adjustments | 0 | 0 | -0 | - | 0 | -0 |
Net Cash Flow | -54.66 | -7.8 | -1.19 | -45.85 | 84.25 | 9.45 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Levered Free Cash Flow | -84.84 | -62.83 | -62.5 | 18.74 | -86.61 | -43.28 |
Unlevered Free Cash Flow | -84.84 | -62.27 | -61.99 | 19.24 | -86.43 | -43.21 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 2.38 | 2.38 | 0.98 | 0.12 | 0.12 | 0.11 |
Cash Income Tax Paid | - | -8.16 | -8.43 | -8.47 | -7.86 | -4.63 |
Change in Working Capital | -16.56 | 7.49 | -18.28 | 30.37 | -20.35 | 7.1 |